S&P 500   3,670.03 (+1.34%)
DOW   29,904.22 (+0.90%)
QQQ   303.40 (+1.26%)
AAPL   123.16 (+3.45%)
MSFT   214.65 (+0.27%)
FB   288.08 (+4.01%)
GOOGL   1,798.60 (+2.52%)
AMZN   3,198.12 (+0.95%)
TSLA   584.81 (+3.03%)
NVDA   540.34 (+0.80%)
BABA   264.63 (+0.48%)
CGC   28.05 (-2.60%)
GE   10.34 (+1.57%)
MU   67.78 (+5.76%)
AMD   93.74 (+1.17%)
T   28.84 (+0.31%)
NIO   47.54 (-5.92%)
F   9.29 (+2.31%)
ACB   10.99 (-5.91%)
NFLX   504.11 (+2.73%)
BA   216.15 (+2.58%)
GILD   61.61 (+1.55%)
DIS   150.70 (+1.82%)
S&P 500   3,670.03 (+1.34%)
DOW   29,904.22 (+0.90%)
QQQ   303.40 (+1.26%)
AAPL   123.16 (+3.45%)
MSFT   214.65 (+0.27%)
FB   288.08 (+4.01%)
GOOGL   1,798.60 (+2.52%)
AMZN   3,198.12 (+0.95%)
TSLA   584.81 (+3.03%)
NVDA   540.34 (+0.80%)
BABA   264.63 (+0.48%)
CGC   28.05 (-2.60%)
GE   10.34 (+1.57%)
MU   67.78 (+5.76%)
AMD   93.74 (+1.17%)
T   28.84 (+0.31%)
NIO   47.54 (-5.92%)
F   9.29 (+2.31%)
ACB   10.99 (-5.91%)
NFLX   504.11 (+2.73%)
BA   216.15 (+2.58%)
GILD   61.61 (+1.55%)
DIS   150.70 (+1.82%)
S&P 500   3,670.03 (+1.34%)
DOW   29,904.22 (+0.90%)
QQQ   303.40 (+1.26%)
AAPL   123.16 (+3.45%)
MSFT   214.65 (+0.27%)
FB   288.08 (+4.01%)
GOOGL   1,798.60 (+2.52%)
AMZN   3,198.12 (+0.95%)
TSLA   584.81 (+3.03%)
NVDA   540.34 (+0.80%)
BABA   264.63 (+0.48%)
CGC   28.05 (-2.60%)
GE   10.34 (+1.57%)
MU   67.78 (+5.76%)
AMD   93.74 (+1.17%)
T   28.84 (+0.31%)
NIO   47.54 (-5.92%)
F   9.29 (+2.31%)
ACB   10.99 (-5.91%)
NFLX   504.11 (+2.73%)
BA   216.15 (+2.58%)
GILD   61.61 (+1.55%)
DIS   150.70 (+1.82%)
S&P 500   3,670.03 (+1.34%)
DOW   29,904.22 (+0.90%)
QQQ   303.40 (+1.26%)
AAPL   123.16 (+3.45%)
MSFT   214.65 (+0.27%)
FB   288.08 (+4.01%)
GOOGL   1,798.60 (+2.52%)
AMZN   3,198.12 (+0.95%)
TSLA   584.81 (+3.03%)
NVDA   540.34 (+0.80%)
BABA   264.63 (+0.48%)
CGC   28.05 (-2.60%)
GE   10.34 (+1.57%)
MU   67.78 (+5.76%)
AMD   93.74 (+1.17%)
T   28.84 (+0.31%)
NIO   47.54 (-5.92%)
F   9.29 (+2.31%)
ACB   10.99 (-5.91%)
NFLX   504.11 (+2.73%)
BA   216.15 (+2.58%)
GILD   61.61 (+1.55%)
DIS   150.70 (+1.82%)
Log in
ASX:ALT

Analytica Limited (ALT.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume37,562 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Analytica Limited designs, develops, and supplies medical devices in Australia, the United Kingdom, and the United States. The company's lead product is PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Autostart Burette Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited was incorporated in 1985 and is based in Brisbane, Australia.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 7 3278 1950
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$805,905.00

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableOptionable

Receive ALT News and Ratings via Email

Sign-up to receive the latest news and ratings for ALT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Analytica Limited (ALT.AX) (ASX:ALT) Frequently Asked Questions

What stocks does MarketBeat like better than Analytica Limited (ALT.AX)?

Wall Street analysts have given Analytica Limited (ALT.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Analytica Limited (ALT.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Analytica Limited (ALT.AX)'s key competitors?

Who are Analytica Limited (ALT.AX)'s key executives?

Analytica Limited (ALT.AX)'s management team includes the following people:
  • Dr. Michael Monsour, Exec. Chairman
  • Mr. Geoff Daly BE (Hons, Mech, UQ), MBA (Exec, AGSM), MIEAust CPE, Chief Exec. Officer
  • Mr. Ross Mangelsdorf B.Bus, FCA, CTA, FTIA, MAICD, CFO & Exec. Director
  • Ms. Chelsea Cornelius, Product Devel. & Operations Mang.
  • Ms. Megan Henken, VP of Global Marketing
  • Mr. Bryan Dulhunty C.A., BEc, ACA, Company Sec.

What is Analytica Limited (ALT.AX)'s stock symbol?

Analytica Limited (ALT.AX) trades on the ASX under the ticker symbol "ALT."

How big of a company is Analytica Limited (ALT.AX)?

Analytica Limited (ALT.AX) has a market capitalization of $0.00 and generates $805,905.00 in revenue each year. Analytica Limited (ALT.AX) employs 2 workers across the globe.

What is Analytica Limited (ALT.AX)'s official website?

The official website for Analytica Limited (ALT.AX) is www.analyticamedical.com.

How can I contact Analytica Limited (ALT.AX)?

The company can be reached via phone at 61 7 3278 1950.

This page was last updated on 12/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.